Ingevity/$NGVT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Ingevity
Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The Company generates the majority of its revenue from North America.
Ticker
$NGVT
Sector
Primary listing
NYSE
Employees
1,600
Headquarters
Website
Ingevity Metrics
BasicAdvanced
$2B
-
-$5.96
1.41
-
Price and volume
Market cap
$2B
Beta
1.41
52-week high
$60.77
52-week low
$28.49
Average daily volume
229K
Financial strength
Current ratio
1.364
Quick ratio
0.706
Long term debt to equity
1,023.695
Total debt to equity
1,139.768
Interest coverage (TTM)
3.26%
Profitability
EBITDA (TTM)
392.8
Gross margin (TTM)
36.94%
Net profit margin (TTM)
-16.35%
Operating margin (TTM)
22.32%
Effective tax rate (TTM)
11.59%
Revenue per employee (TTM)
$830,000
Management effectiveness
Return on assets (TTM)
8.87%
Return on equity (TTM)
-106.83%
Valuation
Price to revenue (TTM)
1.471
Price to book
16.19
Price to tangible book (TTM)
-12.02
Price to free cash flow (TTM)
12.973
Free cash flow yield (TTM)
7.71%
Free cash flow per share (TTM)
4.131
Growth
Revenue change (TTM)
-14.44%
Earnings per share change (TTM)
-49.95%
3-year revenue growth (CAGR)
-4.38%
10-year revenue growth (CAGR)
2.59%
3-year earnings per share growth (CAGR)
17.17%
10-year earnings per share growth (CAGR)
8.12%
What the Analysts think about Ingevity
Analyst ratings (Buy, Hold, Sell) for Ingevity stock.
Bulls say / Bears say
Adjusted EBITDA margin expanded to 30.1% in Q2 2025, up 420 basis points year-over-year, reflecting the success of Performance Chemicals repositioning actions in improving product mix and cost structure (Investing.com)[turn0search1]
Free cash flow surged to $66.8 million in Q2 2025, compared to negative cash flow in the year-ago period, enabling accelerated deleveraging and strengthening the balance sheet (Investing.com)[turn0search1]
The Performance Materials segment maintained robust profitability with a 50.1% EBITDA margin in Q2 2025 despite a 2.1% sales decline, underscoring resilience in automotive carbon products demand (Investing.com)[turn0search1]
Net sales declined 7% year-over-year to $365.1 million in Q2 2025, marking consecutive quarterly revenue drops in its core Performance Chemicals segment (BusinessWire)[turn7search3]
Ingevity recorded a net loss of $146.5 million in Q2 2025, driven primarily by a $183.8 million pre-tax goodwill impairment charge in its Advanced Polymer Technologies segment due to heightened trade uncertainty (BusinessWire)[turn7search3]
In September 2025, Ingevity agreed to divest its North Charleston crude tall oil refinery and majority of its Industrial Specialties product line for $110 million, potentially reducing future revenue streams and adding execution risk during the transition (Ingevity)[turn6search0]
Data summarised monthly by Lightyear AI. Last updated on 2 Oct 2025.
Ingevity Financial Performance
Revenues and expenses
Ingevity Earnings Performance
Company profitability
Ingevity News
AllArticlesVideos
Ingevity announces agreement to sell North Charleston crude tall oil refinery and majority of Industrial Specialties product line to Mainstream Pine Products
Business Wire1 month ago
Ingevity reports second quarter 2025 financial results
Business Wire2 months ago
Ingevity announces dates for second-quarter 2025 earnings release and webcast
Business Wire3 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Ingevity stock?
Ingevity (NGVT) has a market cap of $2B as of October 14, 2025.
What is the P/E ratio for Ingevity stock?
The price to earnings (P/E) ratio for Ingevity (NGVT) stock is 0 as of October 14, 2025.
Does Ingevity stock pay dividends?
No, Ingevity (NGVT) stock does not pay dividends to its shareholders as of October 14, 2025.
When is the next Ingevity dividend payment date?
Ingevity (NGVT) stock does not pay dividends to its shareholders.
What is the beta indicator for Ingevity?
Ingevity (NGVT) has a beta rating of 1.41. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.